These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18767407)

  • 21. The use of selective serotonin reuptake inhibitors in children and adolescents with major depression.
    Scahill L; Hamrin V; Pachler ME
    J Child Adolesc Psychiatr Nurs; 2005; 18(2):86-9. PubMed ID: 15966952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between Selective Serotonin Reuptake Inhibitor Therapy and Suicidality: Analysis of U.S. Food and Drug Administration Adverse Event Reporting System Data.
    Umetsu R; Abe J; Ueda N; Kato Y; Matsui T; Nakayama Y; Kinosada Y; Nakamura M
    Biol Pharm Bull; 2015; 38(11):1689-99. PubMed ID: 26521821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depression in children and adolescents.
    Son SE; Kirchner JT
    Am Fam Physician; 2000 Nov; 62(10):2297-308, 2311-2. PubMed ID: 11126856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Selective serotonin reuptake inhibitors (SSRI's) are not indicated for children and adolescents with depression].
    Lekkerkerker JF; Schobben AF; van Dissel JT; Hekster YA; Hoes AW; Mulder GJ; Neef C; Peeters MF; van Ree JM; Rosmalen CF; Schellekens H; Schellens JH; Silberbusch J
    Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1870-1; author reply 1871-2. PubMed ID: 16128186
    [No Abstract]   [Full Text] [Related]  

  • 25. Empirically Supported Use of Psychiatric Medications in Adolescents and Adults with IBD.
    Thorkelson G; Bielefeldt K; Szigethy E
    Inflamm Bowel Dis; 2016 Jun; 22(6):1509-22. PubMed ID: 27167571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Suicidality in depressive children and adolescents during treatment with selective serotonin reuptake inhibitors. Review and meta-analysis of the available randomised, placebo controlled trials].
    Holtmann M; Bölte S; Poustka F
    Nervenarzt; 2006 Nov; 77(11):1332-7. PubMed ID: 15986258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatrician and family physician prescription of selective serotonin reuptake inhibitors.
    Rushton JL; Clark SJ; Freed GL
    Pediatrics; 2000 Jun; 105(6):E82. PubMed ID: 10835095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficacy of selective serotonin reuptake inhibitor treatment in children and adolescents].
    Bailly D
    Presse Med; 2006 Sep; 35(9 Pt 2):1293-302. PubMed ID: 16969324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychopharmacology. FDA weighs suicide risk in children on antidepressants.
    Holden C
    Science; 2004 Feb; 303(5659):745. PubMed ID: 14764841
    [No Abstract]   [Full Text] [Related]  

  • 30. Update on Common Psychiatric Medications for Children.
    Sharma A
    Pediatr Ann; 2018 Aug; 47(8):e311-e316. PubMed ID: 30102754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The treatment of adolescent depression in the era of the black box warning.
    Richmond TK; Rosen DS
    Curr Opin Pediatr; 2005 Aug; 17(4):466-72. PubMed ID: 16012257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of the 2004 Food and Drug Administration pediatric suicidality warning on antidepressant and psychotherapy treatment for new-onset depression.
    Valluri S; Zito JM; Safer DJ; Zuckerman IH; Mullins CD; Korelitz JJ
    Med Care; 2010 Nov; 48(11):947-54. PubMed ID: 20856141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
    Goodyer IM; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
    Health Technol Assess; 2008 May; 12(14):iii-iv, ix-60. PubMed ID: 18462573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drug treatment of depression in children and adolescents].
    Grøholt B
    Tidsskr Nor Laegeforen; 2011 Nov; 131(22):2243-5. PubMed ID: 22085951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluoxetine: new indication. Depression in children: too many uncertainties.
    Prescrire Int; 2008 Oct; 17(97):186-7. PubMed ID: 19534039
    [No Abstract]   [Full Text] [Related]  

  • 36. [Administration of selective serotonin reuptake inhibitors (SSRI) for depression in children and adolescents].
    Fegert JM; Herpertz-Dahlmann B
    Nervenarzt; 2004 Sep; 75(9):908-10. PubMed ID: 15316621
    [No Abstract]   [Full Text] [Related]  

  • 37. A question of balance.
    Ramchandani P
    Nature; 2004 Jul; 430(6998):401-2. PubMed ID: 15269742
    [No Abstract]   [Full Text] [Related]  

  • 38. Risk of suicide and SSRIs.
    Hanna N; Karabelnik L; Ranga J
    Conn Med; 2005 Oct; 69(9):541-6. PubMed ID: 16270791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using acute tryptophan depletion to investigate predictors of treatment response in adolescents with major depressive disorder: study protocol for a randomised controlled trial.
    Stewart RM; Hood SD; Rao P; Moore JK; Runions KC; Murphy SE; Wong JWY; Zepf FD
    Trials; 2018 Aug; 19(1):434. PubMed ID: 30097056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents.
    Gibbons RD; Brown CH; Hur K; Marcus SM; Bhaumik DK; Erkens JA; Herings RM; Mann JJ
    Am J Psychiatry; 2007 Sep; 164(9):1356-63. PubMed ID: 17728420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.